相关实验视频

Updated: Jul 23, 2025

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

在患有莱维体的痴呆症和患有痴呆症的帕金森病之间,状多巴胺转运体结合有所不同

Kunihiko Ishizawa¹, Yukio Fujita¹, Kazuaki Nagashima¹

¹Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan.

Journal of the neurological sciences

|July 13, 2023

概括

对123I-ioflupane SPECT成像的基于voxel的分析显示,在帕金森综合征中,条状多巴胺载体 (DAT) 结合的明显模式. 这种神经成像方法可能有助于区分患有莱维体 (DLB) 的痴呆症与患有痴呆症 (PDD) 的帕金森病.

科学领域:

神经成像是一种神经成像.
神经学神经学
核医学就是核医学.

背景情况:

帕金森综合征 (PS) 存在诊断挑战,特别是区分患有莱维体的痴呆症 (DLB) 与患有痴呆症的帕金森病 (PDD).
对123I-ioflupane SPECT扫描的视觉检查和兴趣区域分析在区分这些PS时存在局限性.
狭性多巴胺载体 (DAT) 结合模式可能为差异诊断提供一种更客观的方法.

研究的目的:

为了研究基于voxel分析的123I-ioflupane SPECT成像在区分各种帕金森综合征的实用性.
描述和比较DLB,帕金森病 (PD),PDD,多系统缩与主要帕金森症 (MSA-P) 和渐进性超核性麻 (PSP) 的条纹性DAT结合模式.

主要方法:

从被诊断患有DLB,PD,PDD,MSA-P和PSP的患者获得123I-ioflupane SPECT数据.
基于voxel的分析的应用,以评估条形状的DAT结合特征.
DAT结合与临床帕金森症严重程度的相关性以及对海马缩影响的评估.

主要成果:

在PD和PDD中观察到后条纹DAT结合的减少,但在MSA-P,PSP或DLB中没有.
在DLB患者中,海马缩并没有显著影响条纹性DAT结合.
在PD和PDD中发现了前条纹DAT结合和帕金森症严重程度之间的反向相关性,但在DLB中没有.

结论:

对123I-ioflupane SPECT的基于voxel的分析揭示了明显的条状DAT结合模式,可以帮助区分PS.
观察到的DAT结合特征的差异表明DLB和PDD的潜在不同的潜在病理过程.
这种神经成像方法有望改善复杂帕金森综合征的差分诊断.

关键词:

(123) I-ioflupane 单光子发射计算机断层扫描痴呆症与利维体的痴呆症.多巴胺运输体是多巴胺的运输体.帕金森病伴随着痴呆症的发生基于Voxel的分析

更多相关视频

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....